EUCTR2009-010759-29-BE进行中（未招募）1 期
étude clinique sur l’administration de 3 doses de betaméthasone (12mg) à 18 heures d’intervalle lors d’une menace d’accouchement prématuré dans les grossesses gémellaires traitées par Atosiban, plutôt que 2 doses de betaméthasone (12mg) à 24 heures d’intervalle; afin de diminuer le risque de syndrome de détresse respiratoire chez les nouveau-nés . - CORTGEM
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •1. sign inform consent
- •2. normal twin pregnancy
- •3. mother's age between 18 and 40 years old
- •4. premature delivery risk based on the cardiotocography analysis (> 6 contractions / 30 minutes) with open cervix (> 1 cm) on digital examination and/or ultrasound cervical length < 25 mm
- •5. treatment with atosiban
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years)
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. medical contra-indication for tocolysis (mother or fetus)
- •2. fetal distress based on the cardiotocography and/or ultrasouind
- •3. Contra-indication to corticoïd (infection)
- •4. Other treatment with corticoïd (local or general)
- •5. Previous administration of corticoïds for lung maturation in this pregnancy
- •6. Diabetes melitus with insuline therapy
研究者
相似试验
进行中（未招募）
1 期
Clinical trial of a new protocol of lung maturation by administration of corticoids in twin pregnancy patients with threatened preterm birth treated by Atosiban : administration of 3 doses of betamethasone (12 mg) in 18 hours apart, rather than 2 doses of betamethasone (12 mg) in 24 hours apart as used usually, to decrease the risk of respiratory distress syndrome at the newborn childrePremature delivery in twin pregnanciesMedDRA version: 19.1Level: LLTClassification code 10028244Term: Multiple pregnancy affecting fetus or newbornSystem Organ Class: 100000004868MedDRA version: 19.1Level: LLTClassification code 10036564Term: Pregnancy multipleSystem Organ Class: 100000004868EUCTR2016-003603-61-BE50
尚未招募
4 期
The Role of Triphala Rasayana Regimen in Dyslipidaemia (-Medhodushti)CTRI/2023/02/049545Ch.Brahm prakash Ayurved charak Sansthan.
进行中（未招募）
1 期
Investigation of efficacy and safety of three dose levels of subcutaneous semaglutide once daily versus placebo in subjects with non-alcoholic steatohepatitis.on-alcoholic steatohepatitisMedDRA version: 19.0Level: PTClassification code 10053219Term: Non-alcoholic steatohepatitisSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2016-000685-39-FRovo Nordisk A/S372
进行中（未招募）
1 期
Investigation of efficacy and safety of three dose levels of subcutaneous semaglutide once daily versus placebo in subjects with non-alcoholic steatohepatitis.on-alcoholic steatohepatitisMedDRA version: 19.0Level: PTClassification code 10053219Term: Non-alcoholic steatohepatitisSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2016-000685-39-FIovo Nordisk A/S372
进行中（未招募）
1 期
Investigation of efficacy and safety of three dose levels of subcutaneous semaglutide once daily versus placebo in subjects with non-alcoholic steatohepatitis.on-alcoholic steatohepatitisMedDRA version: 20.1Level: PTClassification code 10053219Term: Non-alcoholic steatohepatitisSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2016-000685-39-DKovo Nordisk A/S288